
Peptide bioregulators are short synthetic peptides — most often two to seven amino acid residues — studied for their capacity to enter cell nuclei and influence gene expression[1]. Pinealon, Epithalon, and Cartalax are usually grouped together, but they are chemically distinct and their evidence sits at different levels. Pinealon is a tripeptide with the sequence Glu-Asp-Arg. Epithalon (also spelled Epitalon) is a tetrapeptide, Ala-Glu-Asp-Gly. Cartalax is a tripeptide, Ala-Glu-Asp.
What "peptide bioregulator" means
The term describes a group of short synthetic peptides studied for a direct, sequence-dependent action on gene expression. In this framework, peptide bioregulators are short peptides of two to seven residues that can penetrate into the nuclei and nucleoli of cells and interact with the nucleosome, histone proteins, and both single- and double-stranded DNA[1]. Sequence recognition in gene promoters matters for replication, transcription, and repair, and these peptides can regulate DNA methylation — an epigenetic mechanism that activates or represses genes in normal, pathological, and aging states[1]. Short peptides are proposed to have been evolutionarily among the first signaling molecules[1].
The model holds that a three- or four-residue peptide binds DNA or histones and thereby changes transcription without a conventional receptor. This mechanism is a working hypothesis.
An ordinary peptide or protein is a long chain that folds into defined three-dimensional domains and usually works through catalytic or binding sites. At three or four residues these peptides are far too short to fold into such domains, so the proposed activity depends on direct, sequence-specific interaction with DNA and histones[1].
Pinealon (Glu-Asp-Arg)
Pinealon, also called the EDR peptide, is a synthetic tripeptide built from L-glutamic acid, L-aspartic acid, and L-arginine. Its molecular formula is C15H26N6O8, its molar mass is 418.407, and its CAS number is 175175-23-2[2]. Pinealon has been proposed as a geroprotector[2].
In cell culture, Pinealon restricted reactive oxygen species accumulation in a dose-dependent way in cerebellar granule cells, neutrophils, and PC12 cells exposed to oxidative stress, and reduced necrotic cell death measured by propidium iodide staining. The protection came with delayed ERK 1/2 activation and changes to the cell cycle. ROS restriction saturated at lower concentrations while cell-cycle modulation continued at higher ones, a pattern that suggests Pinealon may also interact directly with the cell genome[3]. These are cell-culture findings; whole-animal and human effects are studied separately.
In rat studies, Pinealon protected offspring from prenatal hyperhomocysteinemia, improved postnatal cognitive function, and maintained learning retention in experimentally induced diabetes[2]. These are animal findings.
EDR activates expression of proteins involved in maintaining neuronal activity and reduces apoptosis in vitro and in vivo. In neuronal cultures from mice modeling Alzheimer’s and Huntington’s disease, EDR interfered with the elimination of dendritic spines; in rat cerebellar neuron cultures it promoted antioxidant enzyme synthesis. EDR normalizes behavioral responses in animal studies, and memory improvement in elderly patients has been reported for it[4]. EDR is proposed to enter cells and bind histone proteins or RNA, altering MAPK/ERK signaling and the synthesis or activity of caspase-3, p53, SOD2, GPX1, PPARA, PPARG, serotonin, and calmodulin. Effects on JNK, p38, and ERK5 remain unstudied[4].
Epithalon (Ala-Glu-Asp-Gly)
Epithalon, also spelled Epitalon, is a tetrapeptide with the sequence Ala-Glu-Asp-Gly, molecular formula C14H22N4O9, and molar mass 390.349. It is the putative active component of epithalamin, a bovine pineal extract[5].
In human fibroblast cultures, Epitalon appears to induce telomere elongation through increased telomerase activity in somatic cells. In human fetal fibroblasts, Epitalon-driven telomere elongation surpassed the Hayflick limit: control cells stopped at the 34th passage, while treated cells continued beyond the 44th[5]. Epitalon also induces decondensation of heterochromatin near centromeres in cultured lymphocytes from people aged 76 to 80, and appears to inhibit MMP9 synthesis in aging skin fibroblasts[5].
In rodents, Epitalon lowered chromosomal damage in wild-type and accelerated-aging mice, raised superoxide dismutase, glutathione peroxidase and glutathione-S-transferase activity in aging rats, and reduced spontaneous tumors and metastases in C3H/He mice. In neonatally hypophysectomized chickens it promoted recovery of thymus and thyroid structure, and in aging rats under constant illumination or a northern-region light regimen it extended lifespan[5].
In small studies, most of them from a single research group at the St Petersburg Institute of Bioregulation and Gerontology, Epitalon and epithalamin appeared to lengthen blood-cell telomeres in people aged 60 to 65 and 75 to 80 and to restore melatonin secretion in aged monkeys and humans, and one retinitis pigmentosa trial reported a positive effect in 90% of treated patients[5]. In pulmonary tuberculosis patients Epitalon appeared protective against new chromosomal aberrations while pre-existing ones persisted; a cohort of 266 people over 60 given epithalamin reported 1.6- to 1.8-fold lower mortality over six years, and a 12-year follow-up of 79 coronary patients described better endurance and lipid metabolism with 50% lower cardiovascular mortality, though the compound used in that cohort is unspecified[5].
Telomere length in blood cells is a biomarker; clinical outcomes are measured separately.
Cartalax (Ala-Glu-Asp)
Cartalax, also designated T-31 or AED, is a tripeptide developed in Russia with the sequence Ala-Glu-Asp, molecular formula C12H19N3O8, and molar mass 333.297[6].
Cartalax has shown anti-aging effects in cell culture and in animal models, and human data remain limited to small published reports. It has been sold in Russian-speaking countries and more broadly online as a supposed treatment for conditions such as arthritis[6].
Cartalax has been studied in cell renewal in kidney tissue cultures from young and old animals, in skin fibroblast aging in vitro, in gene-expression changes in aging human mesenchymal stem cell cultures, in neuronal differentiation of stem cells, and in kidney morphology in old rats[6].
Comparing the three

All three peptides contain a Glu-Asp pair in their sequence. Pinealon places arginine at the C-terminus; Epitalon adds a C-terminal glycine to the Ala-Glu-Asp core; Cartalax is the bare Ala-Glu-Asp tripeptide. The shared Glu-Asp pair is a structural feature; its functional importance remains an open question.
| Peptide | Sequence | Formula / molar mass | In vitro | Animal | Human |
|---|---|---|---|---|---|
| Pinealon | Glu-Asp-Arg | C15H26N6O8 / 418.407 | ROS restriction and reduced necrosis in neuronal and PC12 cultures[3] | Cognitive and metabolic studies in rats[2] | Memory in elderly patients, without published trial detail[4] |
| Epithalon | Ala-Glu-Asp-Gly | C14H22N4O9 / 390.349 | Telomerase activation, telomere elongation, heterochromatin changes[5] | Tumor, enzyme, thymus, and lifespan studies in mice, rats, and chickens[5] | Telomere length and melatonin (both compounds); a retinitis pigmentosa trial; an epithalamin mortality cohort; tuberculosis and coronary follow-up with the compound unspecified[5] |
| Cartalax | Ala-Glu-Asp | C12H19N3O8 / 333.297 | Fibroblast and stem-cell aging cultures[6] | Kidney and tissue studies in old rats[6] | Limited human reports[6] |
Evidence levels for the three peptides

Telomerase activity and telomere length show that a peptide reaches the enzyme or the chromosome end; chromosomal aberration counts reflect genomic stability; superoxide dismutase and glutathione peroxidase activity reflects redox handling in the tissue sampled. Cohort results also need a compound check, because the coronary follow-up does not name the compound used and its outcome cannot be assigned to the synthetic tetrapeptide.
A telomerase readout in a fibroblast culture, a tumor count in a mouse strain, and a mortality reduction in a cohort measure different things; only the cohort addresses clinical outcomes.
None of the three has an approved medical use.
Related research: What Is Epithalon; What Is Pinealon? Structure, Sequence, and Research; Epithalon; Pinealon.
SaiyanMed provides these materials for research use only.
References
- Peptide Regulation of Gene Expression: A Systematic Review (Khavinson et al., Molecules 2021)
- Pinealon (Wikipedia)
- Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes (Khavinson et al., Rejuvenation Research 2011)
- EDR Peptide: Possible Mechanism of Gene Expression and Protein Synthesis Regulation Involved in the Pathogenesis of Alzheimer’s Disease (Khavinson et al., Molecules 2020)
- Epitalon (Wikipedia)
- Cartalax (Wikipedia)